Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress plays a role in female pattern baldness, causing an imbalance between harmful and protective elements in the body.

Oral dutasteride improves hair growth, reduces hair loss, and is safe for most patients.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

New shampoo with tyramine hydrochloride reduces hair loss by making a small muscle in the hair follicle contract.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Enzyme booster SULT1A1 greatly enhances hair regrowth with minoxidil.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Men with hair loss feel it affects their emotions and life quality, and want more effective treatments.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

The report concludes that atypical Brauer nevus is more common in males, present at birth, and often misdiagnosed due to its unusual scalp locations.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Targeting hair follicles can improve skin treatments and reduce side effects.

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

TrichoScan is a reliable method for measuring hair growth and is useful for assessing hair loss treatments.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

Oral minoxidil and topical minoxidil 5% both effectively improve female-pattern hair loss with safe side effects.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

The normal range for the hair pull test is 2 hairs or fewer, and washing or brushing hair before the test does not affect the results.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Hair loss in women not always linked to increased oil production; other factors may be involved.